[
  {
    "ts": null,
    "headline": "QuidelOrtho Corporation (QDEL): A Bull Case Theory",
    "summary": "We came across a bullish thesis on QuidelOrtho Corporation on Valueinvestorsclub.com by Novana. In this article, we will summarize the bulls’ thesis on QDEL. QuidelOrtho Corporation’s share was trading at $27.39 as of July 25th. QDEL’s trailing and forward P/E were 9.16 and 11.22, respectively according to Yahoo Finance. QuidelOrtho (“Quidel”) represents a structurally growing diagnostics franchise […]",
    "url": "https://finnhub.io/api/news?id=06f05a10b9ad1f25fdaced1b190e4a731839f3c28aa5ef6387f877c172c33757",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754328773,
      "headline": "QuidelOrtho Corporation (QDEL): A Bull Case Theory",
      "id": 136200326,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on QuidelOrtho Corporation on Valueinvestorsclub.com by Novana. In this article, we will summarize the bulls’ thesis on QDEL. QuidelOrtho Corporation’s share was trading at $27.39 as of July 25th. QDEL’s trailing and forward P/E were 9.16 and 11.22, respectively according to Yahoo Finance. QuidelOrtho (“Quidel”) represents a structurally growing diagnostics franchise […]",
      "url": "https://finnhub.io/api/news?id=06f05a10b9ad1f25fdaced1b190e4a731839f3c28aa5ef6387f877c172c33757"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock underperforms Monday when compared to competitors despite daily gains",
    "summary": "Abbott Laboratories stock underperforms Monday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=7f390a9c168a42142a51ea2843f6fad14ec741cc2f9bebe5e80ff74f6de48885",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754325120,
      "headline": "Abbott Laboratories stock underperforms Monday when compared to competitors despite daily gains",
      "id": 136209251,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock underperforms Monday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=7f390a9c168a42142a51ea2843f6fad14ec741cc2f9bebe5e80ff74f6de48885"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On Capital",
    "summary": "There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...",
    "url": "https://finnhub.io/api/news?id=a5ba834aba44dda8a2cc24849b877db138c61b980030b1f7493df5f81d36f3f7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754308833,
      "headline": "Abbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On Capital",
      "id": 136197954,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...",
      "url": "https://finnhub.io/api/news?id=a5ba834aba44dda8a2cc24849b877db138c61b980030b1f7493df5f81d36f3f7"
    }
  },
  {
    "ts": null,
    "headline": "Worried About a Stock Market Crash? These Dividend Stocks Can Help You Ride It Out",
    "summary": "Discover four recession-resistant dividend stocks from stable sectors with decades of payout growth, low payout ratios, and strong analyst ratings.",
    "url": "https://finnhub.io/api/news?id=78978b8f01ec1d11267f3f23e280f0b388f28c81e2e822d61a4f516f572996b8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754307337,
      "headline": "Worried About a Stock Market Crash? These Dividend Stocks Can Help You Ride It Out",
      "id": 136197870,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Discover four recession-resistant dividend stocks from stable sectors with decades of payout growth, low payout ratios, and strong analyst ratings.",
      "url": "https://finnhub.io/api/news?id=78978b8f01ec1d11267f3f23e280f0b388f28c81e2e822d61a4f516f572996b8"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Fund Q2 2025 Commentary",
    "summary": "Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.",
    "url": "https://finnhub.io/api/news?id=0b87039d99d7e9cf0a9a88ab06e6861b276113fa4e554693cfbacf40d7eb67b3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754288400,
      "headline": "Janus Henderson Global Life Sciences Fund Q2 2025 Commentary",
      "id": 136196996,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/172204552/image_172204552.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.",
      "url": "https://finnhub.io/api/news?id=0b87039d99d7e9cf0a9a88ab06e6861b276113fa4e554693cfbacf40d7eb67b3"
    }
  }
]